Deals in Depth: October 2008
Executive Summary
October 2008 dealmaking highlights: China Medical's purchase of the HPV-DNA biosensor chip and SPR technology from Molecular Diagnostics Technologies for $345 million was the leading alliance in terms of $ value. Eli Lilly emerged as the mystery bidder for ImClone, defeating BMS and signing a definitive agreement to buy the biotech for $6.5 billion. In October no FOPOs or IPOs were completed in either industry. Private placements, mostly from early- and late-VC rounds, in biopharmas decreased 31% from last month to $358 million while investments in medical devices were up 1.5x to $296 million.